Characterization of Hepatitis B Virus Molecular Genotypes in Chongqing and Quantitative Serological Markers in Patients during Natural Phases of Chronic Hepatitis B Infection

Background/Aims: The present study was launched to systematically characterize the molecular genotypes and quantitative serological biomarkers during the natural course of chronic hepatitis B (CHB) infection in a patient population from Chongqing, China. Methods: A total of 140 patients were enrolled and grouped according to the natural phases of HBV infection: HBeAg (+) immune tolerance, immune clearance, HBeAg (–) low replicative and reactivation phase. Nested PCR was used for HBV molecular genotyping and chemiluminescent microparticle immunoassay for quantitative serological detection. Results: Subgenotypes B2 and C2 were found to be most prevalent with genotype B patients showing more potent viral activity. HBsAg level was found to be significantly correlated with HBV DNA, HBeAg, age, ALT and AST levels during some phases of CHB. Conclusion: These results indicated that molecular genotyping and quantitative serological detection might be helpful for earlier prediction of the long-term disease outcomes.

[1]  S. Locarnini,et al.  Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. , 2010, Journal of hepatology.

[2]  M. Manns,et al.  Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. , 2010, Journal of hepatology.

[3]  J. Feld,et al.  Endpoints of therapy in chronic hepatitis B , 2009, Hepatology.

[4]  H. Zhuang,et al.  [Establishment of a nested PCR to identify hepatitis B virus genotypes A-D and subgenotypes B1, B2, C1 and C2]. , 2008, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[5]  D. S. Bowden,et al.  New developments in HBV molecular diagnostics and quantitative serology , 2008, Hepatology international.

[6]  前城 達次 Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life , 2008 .

[7]  B. McMahon,et al.  Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. , 2007, Gastroenterology.

[8]  C. Chu,et al.  Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. , 2007, Gastroenterology.

[9]  M. Mizokami,et al.  Different natural courses of chronic hepatitis B with genotypes B and C after the fourth decade of life. , 2007, World journal of gastroenterology.

[10]  J. Kao,et al.  Hepatitis B virus genotype: What should the clinician know? , 2007 .

[11]  Ding‐Shinn Chen,et al.  Therapeutic implications of hepatitis B virus genotypes , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[12]  C. Chu,et al.  Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. , 2005, Journal of hepatology.

[13]  Ding-Shinn Chen,et al.  Global control of hepatitis B virus infection. , 2002, The Lancet. Infectious diseases.